Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
TRLV
Strong BuySecond WindTrulieve Cannabis Corp. · Healthcare · United States · $2.3B · Avg Vol: $14M/d
90
StockRankGet insider-trade alerts
Q
49
V
59
M
82
P/E (TTM)
—
ROE
-47.7%
D/E
0.8x
Dividend %
—
COMPANY DESCRIPTION
Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.2B | 1.1B | 1.2B | 1.2B | -1.0% | 1.1B | 1.0B | 936.4M | -11.0% |
| EPS | -1.31 | -2.79 | -0.82 | -0.61 | — | -2.44 | -1.82 | 0.56 | — |
| Shares | 186.0M | 186.2M | 191.0M | 192.3M | +3.4% | 170.2M | — | — | — |
| Debt | 975.1M | 792.6M | 824.5M | 563.6M | -16.7% | 577.9M | — | — | — |
| Equity | 1.9B | 1.4B | 1.3B | 1.2B | -15.6% | — | — | — | — |
| Op CF | 23.1M | 201.8M | 271.5M | 272.8M | 127.7% | 244.4M | — | — | — |
| Inv CF | -215.1M | -37.5M | -206.6M | 13.5M | — | — | — | — | — |
| Fin CF | 177.8M | -175.6M | -33.4M | -270.5M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)+52.3%
SMA 50SMA 200
Close
$12.27
RSI (14)
77.2
52W High
$13.28
From 52W High
0.9%
SCORE BREAKDOWN
Quality
49
ROIC
-10.5%34.5
ROE
-47.7%19.2
GP/Assets
25.1%54.7
Op. Margin
12.8%69.8
FCF/Assets
6.9%77.8
Piotroski
668.8
Int. Cover
-4.7x27.5
D/E Ratio
0.75x19.1
Current Ratio
5.94x76.8
Value
59
P/E (TTM)
—N/A
EV/EBITDA
8.6x76.4
P/FCF
12.2x78.7
P/B
2.0x62.7
P/S
2.0x68.3
Div Yield
—N/A
Momentum
82
52W High %
92%89.9
RS 6M
83%95.6
SMA 50/200
1.19x86.8
EPS Rev 4W
+132.0%99.7
EPS Rev 12W
—N/A
EPS Improve
+123%79.3
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$2.3B
P/E (Forward)
21.8x
Gross Margin
59.5%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of TRLV are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| TRLV | Trulieve Cannabis Corp.(you) | $2.3B | 90 | Strong Buy |
| BCRX | BioCryst Pharmaceuticals, Inc. | $2.5B | 85 | Strong Buy |
| ANIP | ANI Pharmaceuticals, Inc. | $1.7B | 92 | Strong Buy |
| GTII.CN | Green Thumb Industries Inc. | $1.6B | 94 | Strong Buy |
| INDV | Indivior Pharmaceuticals, Inc. | $4.1B | 94 | Strong Buy |
| PCRX | Pacira BioSciences, Inc. | $1.0B | 85 | Strong Buy |
| AMPH | Amphastar Pharmaceuticals, Inc. | $936M | 95 | Strong Buy |
| ETON | Eton Pharmaceuticals, Inc. | $1.7B | 72 | Buy |
| LNTH | Lantheus Holdings, Inc. | $6.6B | 88 | Strong Buy |
| PAHC | Phibro Animal Health Corporation | $1.5B | 74 | Buy |
Peer medians: ROE -30.5% · P/E 27.0x · Gross margin 58.1%